EP3673899
NASAL POWDER FORMULATION FOR TREATMENT OF HYPOGLYCEMIA
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
16.2.2016:
25.6.2025:
20151167.2
:
15.2.2036:
15.2.2026
:
NASAL POWDER FORMULATION FOR TREATMENT OF HYPOGLYCEMIA
16.2.2016
25.6.2025
15.2.2026
:
Amphastar Pharmaceuticals, Inc.:
11570 Sixth Street, Rancho Cucamonga, CA 91730, US
:
Mantripragada, Sankaram B.:
Indianapolis, Indiana 46206-6288, US
:
Piche, Claude A:
Indianapolis, Indiana 46206-6288, US
:
Van Betsbrugge, Jo Jan Filip:
Indianapolis, Indiana 46206-6288, US
:
201562117031 P:
17.2.2015:
US
:
A61K 9/14, A61K 31/724, A61K 38/26, A61P 3/00, A61P 3/08, A61P 43/00, A61K 45/06, A61M 11/02, A61M 15/08